We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Colgate-Palmolive
CL
$74B
| – | – |
-329,932
| Closed | -$26.3M |
|
552
Centene
CNC
$31.3B
| – | – |
-284,073
| Closed | -$21.1M |
|
|
CNTA
553
DELISTED
Centessa Pharmaceuticals
CNTA
| – | – |
-140,856
| Closed | -$1.12M |
|
554
Vita Coco
COCO
$3.71B
| – | – |
-71,277
| Closed | -$1.83M |
|
555
Coherent
COHR
$65.7B
| – | – |
-628,786
| Closed | -$27.4M |
|
556
ConocoPhillips
COP
$142B
| – | – |
-167,789
| Closed | -$19.5M |
|
557
Cerence
CRNC
$413M
| – | – |
-25,017
| Closed | -$492K |
|
|
CTRA
558
DELISTED
Coterra Energy
CTRA
| – | – |
-1,494,462
| Closed | -$38.1M |
|
559
CVS Health
CVS
$124B
| – | – |
-76,788
| Closed | -$6.06M |
|
560
Cytokinetics
CYTK
$10.7B
| – | – |
-42,652
| Closed | -$3.56M |
|
561
DaVita
DVA
$11.7B
| – | – |
-217,450
| Closed | -$22.8M |
|
562
DXC Technology
DXC
$1.76B
| – | – |
-11,980
| Closed | -$274K |
|
563
Elanco Animal Health
ELAN
$12B
| – | – |
-1,227,165
| Closed | -$18.3M |
|
564
e.l.f. Beauty
ELF
$5.58B
| – | – |
-60,070
| Closed | -$8.67M |
|
|
EMO
565
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.02B
| – | – |
-77,679
| Closed | -$2.71M |
|
566
Edgewell Personal Care
EPC
$1.31B
| – | – |
-371,577
| Closed | -$13.6M |
|
567
Evolent Health
EVH
$417M
| – | – |
-40,957
| Closed | -$1.35M |
|
|
EWCZ
568
DELISTED
European Wax Center
EWCZ
| – | – |
-208,816
| Closed | -$2.84M |
|
569
Expensify
EXFY
$190M
| – | – |
-149,466
| Closed | -$369K |
|
570
Eagle Materials
EXP
$6.52B
| – | – |
-31,908
| Closed | -$6.47M |
|
571
Extreme Networks
EXTR
$3.26B
| – | – |
-11,000
| Closed | -$194K |
|
572
Fortinet
FTNT
$117B
| – | – |
-1,014,630
| Closed | -$59.4M |
|
573
General Dynamics
GD
$105B
| – | – |
-102,040
| Closed | -$26.5M |
|
574
Green Dot
GDOT
$762M
| – | – |
-53,227
| Closed | -$527K |
|
575
GE Aerospace
GE
$391B
| – | – |
-219,771
| Closed | -$22.4M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.